. Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology. 2002 Oct 8;59(7):1034-41. PubMed.


Please login to recommend the paper.


  1. The results are not surprising but reinforce the need for reliable biomarkers of disease progression and early diagnosis.

  2. I agree. We need blood or CSF biomarkers to get early diagnosis.

Make a Comment

To make a comment you must login or register.